BioSpace News Archive

Deals

Tricida Announces Pricing of Public Offering of Common Stock - April 4, 2019

Tricida, Inc. announced the pricing of its public offering of 5,600,000 shares of its common stock at a public offering price of $36.00 per share for total gross proceeds of $201.6 million, before deducting underwriting discounts and commissions and other offering expenses payable by Tricida.

April 3, 2019
·
2 min read
Organizing images from any source to connect multi-modal data

ZEISS ZEN Connect software module is now available for materials researchers at universities, multi-user facilities or industrial labs. It enables users to bring all imaging technologies together – ZEISS or otherwise – to answer their questions.

April 3, 2019
·
2 min read
Job Trends

Second Heart Assist Announces Successful First Demo of Wireless Powered Circulatory Assist Pump Aortic Stent

Second Heart Assist, Inc. together with the Queensland University of Technology shared a video today of a demo test run of their patented groundbreaking wireless heart powered circulatory assist pump aortic stent.

April 3, 2019
·
6 min read
BioCapital

Shimadzu’s Next-Generation Clinical Laboratory Automation Module Fully Automates Processes from Pretreatment to Biological LCMS Analysis

Shimadzu Scientific Instruments (SSI) announces the release of the Clinical Laboratory Automation Module (CLAM-2030), a fully integrated sample pretreatment module for LCMS biological analysis.

April 3, 2019
·
2 min read
Deals

AVEO Pharmaceuticals, Inc. Announces Pricing of $25 Million Underwritten Public Offering

AVEO Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of 21,739,131 shares of common stock and short-term warrants to purchase up to 21,739,131 shares of common stock at a price to the public of $1.15 per share and accompanying warrant.

April 3, 2019
·
4 min read
TTP plc spin-out Cellular Highways Ltd to Commercialise Next-Generation Cell-Sorting Technology

TTP plc invests £1.7m ($2.2m), to fast-track development of first commercial product, Highway 1™, bench-top cell-sorting instrument

April 3, 2019
·
3 min read
Drug Development

DelMar Pharmaceuticals Receives Approval from MD Anderson Cancer Center’s IRB for Protocol Expansion to Include Maintenance Stage MGMT-unmethylated GBM Patients in Ongoing Phase 2 Trial of VAL-083

DelMar Pharmaceuticals, Inc. announced the University of Texas MD Anderson Cancer Center’s Institutional Review Board has approved a trial protocol amendment to expand DelMar’s ongoing Phase 2 clinical trial of VAL-083 in patients with MGMT-unmethylated glioblastoma.

April 3, 2019
·
6 min read
CSC Pharmaceuticals Announces the Launch of the Innovative Migraine and Pain Treatment Developed by APR Applied Pharma Research

APR Applied Pharma Research’s patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other pain areas is now available in Russia, promoted and commercialized with the brand Dialrapid by the leading pharmaceutical company CSC Pharmaceuticals.

April 3, 2019
·
6 min read
Business

Doximity Appoints Teladoc Health CEO Jason Gorevic to Board of Directors

Healthcare Business Leader to Advise Doximity on Growth and Market Strategies

April 3, 2019
·
2 min read
Business

Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing

Ajinomoto Bio-Pharma Services, a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Jean-Baptiste Agnus has joined Aji Bio-Pharma as Vice President of Sales and Marketing.

April 3, 2019
·
2 min read